BIOPATCH™ CHG: Reduce the risk of infections

BIOPATCH^™ CHG: Reduce the risk of infections

BIOPATCH^™ Protective Disk with CHG is the only polyurethane foam disk proven to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI, in patients with central venous or arterial catheters.^1,2

Did you know?

It is estimated that over 54,000 people get a catheter‐related bloodstream infection (CRBSI) every single year in the UK.⁴

It is difficult to predict which patients will get these infections.

The Story of Skin Prep

Within hours of thorough antiseptic application, resident bacteria such as MRSA & MSSA quickly re-colonise the skin surface. Help stop this avoidable patient harm by using BIOPATCH^™ EVERY SINGLE TIME. BIOPATCH^™ has been shown to reduce catheter‐related bloodstream infections (CRBSIs) by up to 60% in central venous and arterial catheters, even when infection rates are low.^1,3

PRE-PREP

POST-PREP

BIOPATCH^™ Indications

BIOPATCH^™ Protective Disk with CHG is the only dressing that meets all the following criteria:

Intended to reduce local infections, catheter related bloodstream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI, in patients with central venous or arterial catheters.^5,6**
Is constructed from polyurethane foam allowing quick absorption of fluid decreasing the likelihood of skin maceration.^5,6**
Is designed to deliver chlorhexidine gluconate a full 360 degree around the catheter insertion site providing optimized coverage and protection.^5,6**

PICC Lines

Central Venous Catheters

Dialysis Catheters

Arterial Catheters

Epidural Catheters

Implanted Venous Ports

External Fixator Pins

Mid Lines

Peripheral Catheter

Drain

How BIOPATCH^™ works

BIOPATCH^™ Protective Disk with CHG vs Tegaderm^™ CHG

BIOPATCH^™ has been shown to exhibit a FASTER RATE OF FLUID ABSORPTION than Tegaderm^™ CHG.^9***

Tegaderm^™ CHG product design has been shown NOT TO PROVIDE 360° COVERAGE OF CHG around the catheter’s insertion site in a porcine model.^{7,10^}

Removing Tegaderm^™ CHG dressing from a catheter after ≥5 days requires approximately TWICE AS MUCH FORCE AS REMOVING A TRANSPARENT DRESSING ALONE (such as would be used to secure BIOPATCH^™ to the skin), according to ex vivo testing.¹¹

BIOPATCH™ Protective Disk with CHG product shot

Clinically Proven

BIOPATCH^™ Protective Disk with CHG has extensive clinical evidence, including:

1 meta‐analysis¹²
15 randomized controlled trials (RCTs)¹²
6 comparative cohorts¹²
19 single‐arm case series¹²
6 conference proceedings¹²
2 case reports¹²

Download Clinical Paper

Simple and Easy to Use

Independent Endorsements

A Class B recommendation to “Consider the use of a chlorhexidine-impregnated sponge dressing in adult patients with a central venous catheter as a strategy to reduce catheter related bloodstream infection.”¹³

BIOPATCH^™ was identified as 1 of 108 innovations that has the potential to make a real difference by transforming both quality and value across the NHS.¹⁴

Our team are on hand to support you with BIOPATCH^®

Training
Demos and support material
Cost benefit analysis
Further information

REQUEST A CALL NOW!